ASND · Ascendis Pharma A/S Ordinary Share
View on chartInsiders & Stakes
| Scott Thomas Smith EVP & Chief Financial Officer | ▲ Buy | Open Market | 4,367 Shares held | 6/2/2026 | View profile |
| Jean Jacques Bienaime Director | ▲ Buy | Open Market | 2,900 Shares held | 8/14/2026 | View profile |
| Flemming Steen Jensen See Remarks | ▼ Sell | Open Market | 0 Shares held | 5/11/2026 | View profile |
Transaction History
| Jean Jacques Bienaime | ▲ Buy | Open Market | 1,100 | $270K | 8/14/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 900 | $222K | 8/14/2026 |
| Scott Thomas Smith | ▲ Buy | Open Market | 100 | $22K | 6/2/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 200 | $45K | 5/29/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 200 | $44K | 5/29/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 100 | $22K | 5/29/2026 |
| Scott Thomas Smith | ▲ Buy | Open Market | 250 | $56K | 5/29/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 200 | $47K | 5/26/2026 |
| Jean Jacques Bienaime | ▲ Buy | Open Market | 200 | $48K | 5/26/2026 |
| Flemming Steen Jensen | ▼ Sell | Open Market | 19,460 | $4.6M | 5/11/2026 |